Biodesix Inc (BDSX)
1.57
+0.01
(+0.64%)
USD |
NASDAQ |
May 17, 16:00
1.57
0.00 (0.00%)
After-Hours: 20:00
Biodesix Total Assets (Quarterly): 87.20M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 87.20M |
| December 31, 2023 | 99.10M |
| September 30, 2023 | 86.79M |
| June 30, 2023 | 77.62M |
| March 31, 2023 | 80.79M |
| December 31, 2022 | 92.91M |
| September 30, 2022 | 63.20M |
| June 30, 2022 | 75.23M |
| March 31, 2022 | 61.65M |
| Date | Value |
|---|---|
| December 31, 2021 | 76.10M |
| September 30, 2021 | 90.00M |
| June 30, 2021 | 101.80M |
| March 31, 2021 | 115.49M |
| December 31, 2020 | 121.07M |
| September 30, 2020 | 46.55M |
| June 30, 2020 | 45.48M |
| December 31, 2019 | 45.03M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
45.03M
Minimum
Dec 2019
121.07M
Maximum
Dec 2020
80.35M
Average
80.79M
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
| Fonar Corp | 209.63M |
| XWELL Inc | 38.99M |
| ProPhase Labs Inc | 90.03M |
| Applied DNA Sciences Inc | 9.176M |
| Veracyte Inc | 1.200B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 92.70M |
| Shareholders Equity (Quarterly) | -5.502M |
| Debt to Equity Ratio | -6.462 |
| Current Ratio | 0.9119 |
| Net Debt Paydown Yield | -1.51% |